首页> 美国卫生研究院文献>Drug Design Development and Therapy >Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents
【2h】

Rational design and synthesis of novel diphenyl ether derivatives as antitubercular agents

机译:新型二苯醚衍生物作为抗结核药的合理设计与合成

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A series of triclosan mimic diphenyl ether derivatives have been synthesized and evaluated for their in vitro antitubercular activity against Mycobacterium tuberculosis H37Rv. The binding mode of the compounds at the active site of enoyl-acyl carrier protein reductase of M. tuberculosis has been explored. Among them, compound >10b was found to possess antitubercular activity (minimum inhibitory concentration =12.5 µg/mL) comparable to triclosan. All the synthesized compounds exhibited low levels of cytotoxicity against Vero and HepG2 cell lines, and three compounds >10a, >10b, and >10c had a selectivity index more than 10. Compound >10b was also evaluated for log P, pKa, human liver microsomal stability, and % protein binding, in order to probe its druglikeness. Based on the antitubercular activity and druglikeness profile, it may be concluded that compound >10b could be a lead for future development of antitubercular drugs.
机译:合成了一系列三氯生模拟二苯醚衍生物,并评估了其对结核分枝杆菌H37Rv的体外抗结核活性。已经研究了化合物在结核分枝杆菌的烯酰基-酰基载体蛋白还原酶的活性位点的结合方式。其中,发现化合物> 10b 具有与三氯生相当的抗结核活性(最低抑制浓度= 12.5 µg / mL)。所有合成的化合物均对Vero和HepG2细胞系表现出低水平的细胞毒性,并且三种化合物> 10a ,> 10b 和> 10c 具有选择性指数还评估了化合物> 10b 的log P,pKa,人肝微粒体稳定性和%蛋白质结合,以探究其药物相似性。根据抗结核活性和药物相似性,可以得出结论,化合物> 10b 可能是抗结核药物未来发展的先导。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号